A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella® Use in a Simulated OTC Environment (LIBRella)
Phase of Trial: Phase III
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms LIBRella
- Sponsors HRA Pharma
- 13 Dec 2017 Planned End Date changed from 1 Dec 2017 to 5 Apr 2018.
- 13 Dec 2017 Planned primary completion date changed from 1 Oct 2017 to 15 Feb 2018.
- 10 Jul 2017 New trial record